Literature DB >> 22909780

Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature.

Alexandre Seidowsky, Maxime Hoffmann, François Glowacki, Claire-Marie Dhaenens, Jean-Philippe Devaux, Celia Lessore de Sainte Foy, François Provot, Jean-Dominique Gheerbrant, Aurelie Hummel, Marc Hazzan, Michel Dracon, Anne Dieux-Coeslier, Marie-Christine Copin, Christian Noël, David Buob.   

Abstract

Renal dysfunction is increasingly recognized as a potential clinical feature of mitochondrial cytopathies such as mitochondrial encephalomyopathy, lacticacidosis and stroke-like episodes (MELAS) syndrome. Five cases of MELAS syndrome with renal involvement from 4 unrelated families are presented in this case series. Three of the 5 patients had a history of maternally-inherited diabetes and/or deafness. Focal and segmental glomerulosclerosis and arteriolar hyaline thickening were the most striking findings on renal biopsy. In addition to clinical presentation with the typical symptoms of MELAS syndrome, genetic testing in these patients identified the A3243G point mutation in the tRNALeu gene of the mitochondrial DNA (mtDNA). The diagnosis of MELAS syndrome was thus considered to be unequivocal. The incidence of kidney disease in MELAS syndrome may be underestimated although a study is required to investigate this hypothesis. As the A3243G mtDNA mutation leads to a progressive adult-onset form of focal segmental glomerulosclerosis (FSGS), screening for the MELAS A3243G mtDNA mutation should therefore be performed especially in patients with maternally-inherited diabetes or hearing loss presenting with FSGS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22909780     DOI: 10.5414/CN107063

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  15 in total

1.  Automated peritoneal dialysis for a patient with hearing loss: a case report.

Authors:  Tsutomu Sakurada; Shigeki Kojima; Daisuke Oishi; Kenichiro Koitabashi; Yugo Shibagaki; Kenjiro Kimura
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

2.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

Review 3.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

Review 4.  Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Authors:  Francesco Emma; Giovanni Montini; Samir M Parikh; Leonardo Salviati
Journal:  Nat Rev Nephrol       Date:  2016-01-25       Impact factor: 28.314

Review 5.  New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease.

Authors:  José Pedraza-Chaverri; Laura G Sánchez-Lozada; Horacio Osorio-Alonso; Edilia Tapia; Alexandra Scholze
Journal:  Oxid Med Cell Longev       Date:  2016-06-27       Impact factor: 6.543

6.  Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.

Authors:  Yasutoshi Koga; Nataliya Povalko; Eisuke Inoue; Hidefumi Nakamura; Akiko Ishii; Yasuhiro Suzuki; Makoto Yoneda; Fumio Kanda; Masaya Kubota; Hisashi Okada; Katsunori Fujii
Journal:  J Neurol       Date:  2018-09-29       Impact factor: 4.849

7.  New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the MT-ND4 Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Autoimmune Syndrome Type 2.

Authors:  Dominique Endres; Patrick Süß; Simon J Maier; Evelyn Friedel; Kathrin Nickel; Christiane Ziegler; Bernd L Fiebich; Franz X Glocker; Friedrich Stock; Karl Egger; Thomas Lange; Michael Dacko; Nils Venhoff; Daniel Erny; Soroush Doostkam; Katalin Komlosi; Katharina Domschke; Ludger Tebartz van Elst
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

8.  Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy.

Authors:  Anna Czajka; Saima Ajaz; Luigi Gnudi; Chandani Kiran Parsade; Peter Jones; Fiona Reid; Afshan N Malik
Journal:  EBioMedicine       Date:  2015-04-11       Impact factor: 8.143

9.  Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus.

Authors:  Maaike C De Vries; David A Brown; Mitchell E Allen; Laurence Bindoff; Gráinne S Gorman; Amel Karaa; Nandaki Keshavan; Costanza Lamperti; Robert McFarland; Yi Shiau Ng; Mar O'Callaghan; Robert D S Pitceathly; Shamima Rahman; Frans G M Russel; Kristin N Varhaug; Tom J J Schirris; Michelangelo Mancuso
Journal:  J Inherit Metab Dis       Date:  2020-02-07       Impact factor: 4.750

10.  Mitochondrial Disease (MELAS Syndrome) Discovered at the Start of Pregnancy in a Patient with Advanced CKD: A Clinical and Ethical Challenge.

Authors:  Domenico Santoro; Gianluca Di Bella; Antonio Toscano; Olimpia Musumeci; Michele Buemi; Giorgina Barbara Piccoli
Journal:  J Clin Med       Date:  2019-03-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.